Direct measurement of the contributions of type I and type II 5′-deiodinases to whole body steady state 3,5,3′-triiodothyronine production from thyroxine in the rat

被引:51
作者
Nguyen, TT
Chapa, F
DiStefano, JJ
机构
[1] Univ Calif Los Angeles, Dept Comp Sci, Biocybernet Lab, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Med, Biocybernet Lab, Los Angeles, CA 90095 USA
关键词
D O I
10.1210/en.139.11.4626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Production of T-3 from T-4 in tissues is catalyzed by two 5'-deiodinases, type I (D1) and type II (D2), but the quantitative contribution of each pathway to whole body T-3 production is not well established. In the presence of propylthiouracil (PTU), D1, but not D2, can be effectively blocked, providing an experimental probe for addressing this problem. Decades ago, this approach provided indirect estimates ranging from 23-44% contribution by D2, based on plasma T-3 appearance rate comparisons (PAR(3) = PCR3 [T-3](p)) in periodically T-4- injected athyreotic rats vs. controls. Two, more recent studies, using constant infusions of T-4 for replacement, achieved 22% and 65% estimates, respectively, from PAR(3) comparisons. We have revisited this problem more directly and precisely, with two major differences in experiment design. We used direct whole body steady state measurements of T-3 production, instead of indirect plasma-only data (PAR(3)). We also used (euthyroid) physiological doses of both T-4 (0.9 mu g/day-100 g BW) and T-2 (0.15 mu g/day-100 g BW) for replacement in two Lhyroidectomized rat groups, instead of T-4 only, in a 7-day constant steady state, dual tracer infusion protocol. The first group also had chronically implanted 150-mg PTU pellets (TXR-PTU); the other had implanted 0.1 N NaOH placebo pellets (TXR-EU); each delivered their product at constant rates. A third euthyroid intact group was used as the controls. The completeness of D1 inhibition was ascertained in a fourth group, identically treated with 150-mg PTU pellets, in which negligible D1 activity was found in liver and kidney using labeled 5'-D as substrate for the 5'-D assays and minimal (1 mM) dithiothreitol as cofactor. In the TXR-PTU group, the percentage of T-4 converted to T-3 was 11.8%, compared with 23.4% (P < 0.0005) in the TXR-EU group, and 22.7% (P = NS) in controls. Thus, in euthyroid steady state, D2 contributes about half of the Ta produced from T-4.
引用
收藏
页码:4626 / 4633
页数:8
相关论文
共 31 条
  • [1] Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system
    CamposBarros, A
    Hoell, T
    Musa, A
    Sampaolo, S
    Stoltenburg, G
    Pinna, G
    Eravci, M
    Meinhold, H
    Baumgartner, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) : 2179 - 2185
  • [2] Cloning of the mammalian type II iodothyronine deiodinase - A selenoprotein differentially expressed and regulated in human and rat brain and other tissues
    Croteau, W
    Davey, JC
    Galton, VA
    StGermain, DL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) : 405 - 417
  • [3] DISTEFANO JJ, 1989, ENDOCRINOLOGY, P2726
  • [4] ESCOB.F, 1961, ENDOCRINOLOGY, V69, P456
  • [5] Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat
    EscobarMorreale, HF
    delRey, FE
    Obregon, MJ
    deEscobar, GM
    [J]. ENDOCRINOLOGY, 1996, 137 (06) : 2490 - 2502
  • [6] Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine
    EscobarMorreale, HF
    Obregon, MJ
    Hernandez, A
    DelRey, FE
    DeEscobar, GM
    [J]. ENDOCRINOLOGY, 1997, 138 (06) : 2559 - 2568
  • [7] CORRELATION OF SERUM TRIIODOTHYRONINE (T3) AND THYROXINE (T4) WITH BIOLOGIC EFFECTS OF THYROID-HORMONE REPLACEMENT IN PROPYLTHIOURACIL-TREATED RATS
    FRUMESS, RD
    LARSEN, PR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (04): : 547 - 554
  • [8] IODOTHYRONINE 5'-DEIODINASE IN BROWN ADIPOSE-TISSUE - THIOL ACTIVATION AND PROPYLTHIOURACIL INHIBITION
    GOSWAMI, A
    ROSENBERG, IN
    [J]. ENDOCRINOLOGY, 1986, 119 (02) : 916 - 923
  • [9] KAPLAN MM, 1986, THYROID HORMONE META, P231
  • [10] LARSEN PR, 1977, ENDOCRINOLOGY, V100, P980